Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameHospital Corp
Stock Code03869
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是由具有豐富醫院管理經驗的專業團隊領導的醫院運營管理集團,通過運營與管理醫院,整合旗下醫院所在區域內的醫療資源,構建區域醫療服務中心,專注於常見病、多發病及慢性病診療,並擁有及經營綜合醫院。
Listing Date2017-03-16
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市海淀區知春路6號錦秋國際大廈B座1602室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehcclhealthcare.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 12.80 / shares
Offer Price RangeTo be extracted
Lot Size200 shares
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2017-02-28 to 2017-03-09
Global Offering Shares33,334,000 shares
HK Public Offer Shares (Initial)3,333,600 shares (10.0%)
Public Offer Lots (Initial)16,668lots (Pool A8,334lots,Pool B8,334lots)
International Placing Shares (Initial)30,000,400 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO133,194,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share6.8%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 426,675,200

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 447.4M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +2071%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣67.3百萬元
Period-End Cash Balance人民幣13.1百萬元
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 2013201420152016-09
Revenue 46,44380,40989,23463,807
Cost of sales -6,170-23,166-32,831-35,160
Gross profit 40,27357,24356,40328,647
Other income and gains, net 541372,47757
Selling and distribution expenses 0-18-1-3
Administrative expenses -1,238-2,848-3,755-3,196
Operating profit 39,08954,44355,01325,526
Profit before tax 39,11855,61055,06625,582
Income tax expense -10,029-14,565-13,772-7,816
Profit for the year 29,08941,04541,29417,766
Profit attributable to owners 29,08941,04541,29417,766
Balance Sheet
Item 2013201420152016-09
Cash and cash equivalents 9,0205,13413,08656,854
Trade and bills receivables 01,5637,4906,588
Inventories 08511,1801,961
Total current assets 43,735168,648132,60985,117
Total assets 64,821207,750172,070124,915
Total current liabilities 24,164176,49899,72458,436
Total liabilities 24,164179,048102,07460,636
Total equity 40,65728,70269,99664,279
Equity attributable to owners 40,65728,70269,99664,279
Cash Flow Statement
Item 20132014-0920142015-0920152016-09
Net cash from operating activities 9,38619,4917,331104,282
Net cash from investing activities -716-103,37780,621-7,514
Net cash from financing activities 080,000-80,000-53,000
Net increase in cash 8,670-3,8867,95243,768
Purchase of PP&E -716-5,259-5,834-976-1,168-7,514
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 12.96
First Day OpenHK$ 13.0
First Day Change1.25%
First Day Volume7777800.0
First Day Turnover99297800.0
Use of Proceeds
1、171.8百萬港元(50%)將用于戰略性收購位于中國的醫院; 2、61.8百萬港元(18%)將不時用于對我們所擁有或管理的醫院(非營利性醫院除外)進一步投資; 3、51.5百萬港元(15%)將用于醫院及我們不時擁有或管理的其他醫院的雇員培訓計劃、人才引進及學術研究活動; 4、24.1百萬港元(7%)將用于升級及改良我們的信息技術系統; 5、34.5百萬港元(10%)將用于為我們的營運資金、租金和物業相關開支及其他一般企業用途提供資金。

Underwriting Syndicate

Sole Sponsor (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Overall Coordinators (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Joint Bookrunners (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Joint Lead Managers (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 安徽省中安健康养老服务 116,464,640 HKD — 6.80% — 6 months 2017-09-16

Directors & Management

PositionChinese nameEnglish Name
Chairman趙令歡—
Company Secretary鄺燕萍—
No director data available.

Major Shareholders

Major Shareholders & HoldingsVanguard Glory及弘毅投資實體為控股股東,緊接全球發售前持有已發行股本97.14%權益;緊隨全球發售完成後(假設超額配股權未獲行使)持有約72.83%權益。
About this page

This page shows Hospital Corp (03869) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect